Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Capecitabine + Lapatinib & Breast Cancer / Mammacarcinoma (HER2+)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Concerning Capecitabine + Lapatinib & Breast Cancer / Mammacarcinoma (HER2+), both the FDA and EMA have approved Capecitabine + Lapatinib for Breast Cancer / Mammacarcinoma (HER2+)

The combination of capecitabine and lapatinib is used in the treatment of HER2-positive advanced or metastatic breast cancer. Lapatinib is a [tyrosine kinase inhibitor](brain://W60qZzVfwUWnyUTAJx7Bow/TyrosineKinaseInhibitorsT…

References (Sources)

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial
Saura et al. 2020 JCO 38: 3138–3149
Pyrotinib or Lapatinib Combined With Capecitabine in HER2–Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study
Ma et al. 2019 JCO 37: 2610–2619
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial
Fehm et al. 2024 The Lancet Oncology 25(5): 614-625

AI Chat

7/2/2026

Chat with our artificial intelligence:

Start chat!

Capecitabine + Lapatinib & Breast Cancer / Mammacarcinoma (HER2+)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat